Could CBD Be An Antibiotic?

The relationship between infection and conventional antibiotics

Could CBD be useful in the fight versus resistant bacterial pressures? The results from the University of Queensland in Australia recommend that it is possible. However prior to examining the research study in depth, it works to comprehend the development of the relationship between germs and antibiotics.

Since the advanced discovery of penicillin by Alexander Fleming in 1928, antibiotics have been an important tool in the fight versus germs and infections. And although we still utilize the same tested methods today, germs have developed. When exposed to antibiotics, particular germs, fungi and parasites are able to adjust and cancel the effectiveness of the drug by establishing resistance.

It’s worth mentioning that antimicrobial resistance was most likely to happen anyway, as the hereditary code for germs changes with time. However, it is believed that the overuse of antibiotics is a crucial factor that speeds up the advancement of resistant pressures. See Nine CBD for further reading.

According to the World Health Organization, antimicrobial resistance “is an increasingly major threat to international public health that requires action in all sectors of federal government and in society.” This has actually led researchers to think outside package by trying to identify substances that could be useful in the fight versus hazardous germs. Among these substances is cannabidiol (CBD), a cannabinoid found in Cannabis sativa.

Researchers are trying to find new ways to assault infections and resistant germs.

Dr. Mark Blaskovich, Principal Investigator and Program Coordinator for the Community for Open Antimicrobial Drug Discovery and Senior Research Officer at the Institute for Molecular Bioscience at the University of Queensland, concluded that CBD works versus Gram-positive germs. Strains of Gram-positive germs consist of Staphylococcus aureus (common in skin infections) and Streptococcus pneumoniae (common in bacterial pneumonia). CBD Gurus is a good resource for this.

Dr. Blaskovich presented his findings at an annual conference of the American Society for Microbiology. In vitro samples of both types of gram-positive germs were treated with artificial CBD. The results led Dr. Blaskovich to the conclusion that CBD operates at levels comparable to those of prescription antibiotics vancomycin and daptomycin. He also found that CBD appeared to work against gram-positive pressures of resistant germs, which lots of standard antibiotics are starting to stop working.

” In particular, the activity was picked versus the resistant pressures of Staphylococcus aureus (MRSA, VISA, SARV), Streptococcus pneumoniae (MDR), and Enterococcus faecalis (ERV). Cannabidiol was bactericidal, had a low propensity to induce resistance and was active versus MRSA biofilms. “

The group also conducted another research study utilizing topical CBD to treat a skin infection in mice. Once again, although the results were positive, CBD did not appear to eliminate the infection, however simply to reduce the variety of bacterial cells.

Could CBD become an antibiotic?

While it is easy to hail this work as a substantial development in the antibacterial capabilities of CBD, it is too soon to give up on penicillin.

Although it is believed that the effectiveness of CBD could originate from the method it attacks the biofilm surrounding bacterial cells, the authors are still uncertain of the mechanism of action of CBD. They also did not hesitate to point out the shortcomings of the research study. Dr. Blaskovich mentioned that considering that the results remain in the preliminary phases, it is far too early for people to begin treating their CBD infections themselves.

The research study was also conducted in vitro (outside the body), and there is a risk that the results of clinical trials will not be the same. Numerous substances have revealed antibacterial efficacy in petri dishes, however then stopped working at this essential stage. It should also be mentioned that the two studies were carried out in cooperation with Botanix Pharmaceuticals Ltd, a pharmaceutical business concentrating on topical CBD products.

However, this research could be a crucial step forward for CBD and the fight versus antimicrobial resistance. CBD continues to have a great security profile and is not considered poisonous even in large amounts. Thankfully, Dr. Blaskovich and his group plan to continue their research.

Scroll to top